0,958  0,001  Antiparkinsonian, rigidity relieving
0,793  0,003  Muscle relaxant
0,760  0,007  Respiratory analeptic
0,750  0,003  Skeletal muscle relaxant
0,734  0,005  5 Hydroxytryptamine release stimulant
0,599  0,004  Sigma receptor agonist
0,605  0,013  Analeptic
0,599  0,029  CYP3A4 substrate
0,578  0,016  CYP1A2 substrate
0,599  0,036  Caspase 9 stimulant
0,548  0,004  Alpha 2 adrenoreceptor antagonist
0,570  0,034  Antineoplastic (lung cancer)
0,533  0,004  Dopamine agonist
0,538  0,012  Cardiodepressant
0,540  0,018  Mutagenic
0,524  0,013  CYP2D6 inhibitor
0,516  0,005  Antiischemic, cerebral
0,509  0,004  5 Hydroxytryptamine 7 antagonist
0,514  0,034  CYP2C9 substrate
0,540  0,063  Apoptosis agonist
0,481  0,006  Alpha adrenoreceptor antagonist
0,495  0,024  Spasmolytic
0,473  0,008  Antineoplastic (squamous cell carcinoma)
0,480  0,016  Hypoxia-inducible factor 1 alpha inhibitor
0,487  0,027  CYP2D6 substrate
0,502  0,044  Transcription factor NF kappa B inhibitor
0,457  0,004  Dopamine D1 antagonist
0,493  0,041  Antiparkinsonian
0,436  0,004  Dopamine D2 agonist
0,459  0,027  Caspase 3 stimulant
0,432  0,010  5 Hydroxytryptamine antagonist
0,426  0,010  Genotoxic
0,408  0,005  Neurotrophic factor enhancer
0,424  0,024  Antineoplastic (glioblastoma multiforme)
0,402  0,006  Antiparkinsonian, tremor relieving
0,425  0,033  Antiischemic
0,440  0,052  Antileukemic
0,431  0,048  CYP2C19 inhibitor
0,424  0,047  Prostate cancer treatment
0,419  0,042  Antidepressant
0,390  0,018  Abortion inducer
0,420  0,050  Stroke treatment
0,372  0,005  Alpha 2a adrenoreceptor antagonist
0,414  0,050  Antineoplastic (colorectal cancer)
0,406  0,049  Antineoplastic (colon cancer)
0,366  0,012  Topoisomerase II inhibitor
0,396  0,045  Hepatic disorders treatment
0,360  0,012  5 Hydroxytryptamine 2 antagonist
0,414  0,068  Histamine release inhibitor
0,385  0,039  Antineoplastic (glioma)
0,348  0,006  Alpha 2b adrenoreceptor antagonist
0,365  0,029  Psychostimulant
0,345  0,011  Antiadrenergic
0,388  0,055  Mood disorders treatment
0,332  0,011  Adrenaline antagonist
0,353  0,037  Antineoplastic (lymphoma)
0,333  0,018  Antineoplastic (carcinoma)
0,323  0,008  5 Hydroxytryptamine 1A antagonist
0,344  0,031  DNA synthesis inhibitor
0,331  0,019  Male reproductive disfunction treatment
0,316  0,009  5 Hydroxytryptamine 1 antagonist
0,317  0,013  Erectile dysfunction treatment
0,340  0,040  Antineoplastic (small cell lung cancer)
0,310  0,010  Topoisomerase I inhibitor
0,305  0,014  Cholinergic antagonist
0,301  0,014  Acetylcholine antagonist
0,335  0,050  UGT1A9 substrate
0,294  0,011  Carcinogenic, group 1
0,330  0,047  DNA damaging
0,297  0,015  Acetylcholine M1 receptor antagonist
0,309  0,027  Hepatoprotectant
0,269  0,004  Antineoplastic alkaloid
0,270  0,012  Acetylcholine muscarinic antagonist
0,320  0,063  Antineoplastic (melanoma)
0,268  0,013  Dopamine antagonist
0,282  0,028  Pneumotoxic
0,350  0,097  Antineoplastic (breast cancer)
0,298  0,049  Vasodilator
0,266  0,017  Toxic, respiratory center
0,252  0,004  Dopamine D5 antagonist
0,258  0,014  5 Hydroxytryptamine 2A antagonist
0,388  0,146  Antiinflammatory
0,292  0,055  Antineoplastic (liver cancer)
0,275  0,040  Anesthetic general
0,276  0,043  Antineoplastic enhancer
0,278  0,045  Tyrosine 3 hydroxylase inhibitor
0,257  0,024  Liver fibrosis treatment
0,282  0,049  Antimitotic
0,262  0,038  P-glycoprotein inhibitor
0,314  0,090  Vasodilator, peripheral
0,275  0,052  Cyclic AMP phosphodiesterase inhibitor
0,241  0,019  Uterine stimulant
0,273  0,051  5 Hydroxytryptamine 1E antagonist
0,329  0,115  Antibacterial
0,294  0,083  CYP3A4 inhibitor
0,280  0,078  Antipsychotic
0,219  0,018  Alpha 1 adrenoreceptor antagonist
0,216  0,015  Dopamine D2 antagonist
0,221  0,023  Antiviral (Hepatitis B)
0,222  0,033  Cystic fibrosis treatment
0,281  0,094  Antineoplastic (brain cancer)
0,210  0,023  DNA intercalator
0,260  0,076  Antiprotozoal (Trypanosoma)
0,201  0,018  Alpha 2c adrenoreceptor antagonist
0,202  0,024  Antitussive
0,253  0,077  Antihypercholesterolemic
0,178  0,006  Restless leg syndrome treatment
0,198  0,027  Alkylator
0,198  0,027  5 Hydroxytryptamine 2B antagonist
0,305  0,138  Analgesic
0,225  0,059  Nitric oxide antagonist
0,183  0,018  Topoisomerase II alpha inhibitor
0,176  0,011  CDC-like kinase 3 inhibitor
0,210  0,046  LDLR expression enhancer
0,198  0,038  Tubulin antagonist
0,179  0,019  Alpha 1a adrenoreceptor antagonist
0,164  0,009  Dopamine uptake inhibitor
0,269  0,115  Vasodilator, coronary
0,162  0,014  Dopamine D3 antagonist
0,163  0,017  Acetylcholine nicotinic antagonist
0,164  0,020  Antiviral (Papilloma)
0,261  0,121  Prostaglandin dehydrogenase inhibitor
0,238  0,098  Antineoplastic (ovarian cancer)
0,177  0,038  Psychosexual dysfunction treatment
0,221  0,083  Cytostatic
0,255  0,117  Antihypertensive
0,223  0,087  Antineoplastic (cervical cancer)
0,237  0,101  CYP2C19 substrate
0,224  0,088  Acute neurologic disorders treatment
0,178  0,053  UGT2B9 substrate
0,180  0,056  Cholinergic
0,231  0,108  Cardioprotectant
0,197  0,074  UGT1A1 substrate
0,187  0,067  UGT2B7 substrate
0,179  0,059  ATPase inhibitor
0,126  0,007  Opioid kappa receptor agonist
0,142  0,025  Prolactin inhibitor
0,145  0,029  Sphingosine 1-phosphate receptor 2 agonist
0,177  0,065  UGT1A3 substrate
0,167  0,057  CDC-like kinase 1 inhibitor
0,194  0,087  Anticonvulsant
0,119  0,014  Acetylcholine M3 receptor antagonist
0,261  0,157  Antineoplastic (myeloid leukemia)
0,206  0,102  Antineoplastic (non-small cell lung cancer)
0,154  0,053  Acetylcholinesterase inhibitor
0,131  0,029  Carcinogenic, group 2A
0,167  0,066  Antiviral (Herpes)
0,112  0,012  Alpha 2 adrenoreceptor agonist
0,293  0,195  Antineoplastic (solid tumors)
0,121  0,024  Phosphodiesterase 6D inhibitor
0,179  0,085  UDP-glucuronosyltransferase substrate
0,114  0,023  Phosphodiesterase 11A inhibitor
0,114  0,023  Phosphodiesterase XI inhibitor
0,195  0,106  NOS2 expression inhibitor
0,177  0,088  Cytotoxic
0,109  0,021  Neuronal nicotinic receptor antagonist
0,110  0,022  Acetylcholine M4 receptor antagonist
0,113  0,025  ATPase (Vacuolar H+) inhibitor
0,114  0,028  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,095  0,009  Nicotinic alpha3beta2 receptor antagonist
0,110  0,024  Nicotinic alpha4beta2 receptor antagonist
0,174  0,088  Sensitization
0,173  0,087  Platelet adhesion inhibitor
0,225  0,140  GST M1-1 substrate
0,091  0,006  Prolactin release inhibitor
0,219  0,137  FMO3 substrate
0,169  0,089  Sedative
0,093  0,013  Antibiotic Glycopeptide-like
0,130  0,051  Microtubule formation inhibitor
0,139  0,060  Antiseptic
0,092  0,014  Dopamine transporter inhibitor
0,193  0,115  Antineoplastic (renal cancer)
0,091  0,014  Nicotinic receptor alpha7 subunit antagonist
0,099  0,025  Narcotic antagonist
0,105  0,031  Opioid kappa receptor antagonist
0,232  0,158  Antiprotozoal (Plasmodium)
0,089  0,016  Opioid mu receptor agonist
0,132  0,059  Anesthetic local
0,103  0,033  5 Hydroxytryptamine agonist
0,195  0,126  Radioprotector
0,233  0,164  Immunosuppressant
0,098  0,029  Phosphodiesterase V inhibitor
0,129  0,060  Adenylate cyclase inhibitor
0,084  0,018  Opioid agonist
0,149  0,083  Melanin inhibitor
0,084  0,018  Alpha tubulin antagonist
0,111  0,046  Breast cancer-resistant protein inhibitor
0,166  0,102  Pyruvate kinase inhibitor
0,083  0,020  Antiviral (Parainfluenza)
0,105  0,042  SULT1E1 substrate
0,186  0,126  Antioxidant
0,064  0,004  Dopamine D1 agonist
0,086  0,026  Acetylcholine M2 receptor antagonist
0,192  0,135  Antineoplastic (pancreatic cancer)
0,199  0,143  UGT2B4 substrate
0,234  0,180  Antiprotozoal
0,090  0,037  Analgesic, opioid
0,082  0,030  Female sexual dysfunction treatment
0,124  0,072  Papain-like protease (SARS coronavirus) inhibitor
0,137  0,086  Adenylate cyclase stimulant
0,083  0,032  5 Hydroxytryptamine 1B antagonist
0,180  0,129  Peptidyltransferase inhibitor
0,210  0,160  ICAM1 expression inhibitor
0,192  0,143  Flavin-containing monooxygenase substrate
0,084  0,034  Antitreponemal
0,092  0,043  Xanthine oxidase substrate
0,173  0,125  5 Hydroxytryptamine 3E antagonist
0,084  0,036  Phosphodiesterase 5A inhibitor
0,078  0,031  Glutamate (mGluR7) antagonist
0,229  0,183  15-Lipoxygenase inhibitor
0,136  0,090  Heat shock protein 70 antagonist
0,146  0,102  Carcinogenic
0,207  0,163  CTGF expression inhibitor
0,090  0,046  Antiprotozoal activity enhancer
0,093  0,050  Antiviral (Hepatitis A)
0,072  0,030  5 Hydroxytryptamine 5A antagonist
0,102  0,060  Estrogen receptor beta antagonist
0,063  0,023  Alpha-mannosidase inhibitor
0,080  0,043  5 Hydroxytryptamine 1F antagonist
0,119  0,083  Anesthetic
0,076  0,041  Alpha adrenoreceptor agonist
0,134  0,099  Ca2+-transporting ATPase inhibitor
0,109  0,076  Estrogen antagonist
0,063  0,030  Ryanodine receptor antagonist
0,089  0,057  Opioid antagonist
0,219  0,187  TNF expression inhibitor
0,057  0,026  5 Hydroxytryptamine 1A agonist
0,070  0,039  5 Hydroxytryptamine uptake inhibitor
0,055  0,024  Factor III inhibitor
0,114  0,085  DNA repair enzyme inhibitor
0,058  0,029  5 Hydroxytryptamine 1B agonist
0,045  0,017  5 Hydroxytryptamine 3B antagonist
0,050  0,022  Phosphodiesterase 6C inhibitor
0,055  0,030  5 Hydroxytryptamine 4 antagonist
0,117  0,093  Antifungal enhancer
0,062  0,038  Beta tubulin antagonist
0,060  0,036  5 Hydroxytryptamine 5 antagonist
0,086  0,062  Sodium/hydrogen exchanger 5 inhibitor
0,184  0,161  Antihypoxic
0,076  0,054  Estrogen receptor alpha antagonist
0,071  0,050  Histidine decarboxylase inhibitor
0,068  0,047  Opioid mu receptor antagonist
0,041  0,022  Vesicle monoamine transporter inhibitor
0,081  0,062  Calcium antagonist
0,116  0,098  Lipid peroxidase inhibitor
0,141  0,125  Antiarrhythmic
0,052  0,036  5 Hydroxytryptamine 2 agonist
0,046  0,031  Mannosidase inhibitor
0,145  0,131  Phobic disorders treatment
0,023  0,010  Vesicular acetylcholine transporter inhibitor
0,048  0,036  Nicotinic receptor alpha4 subunit antagonist
0,027  0,015  Dopamine autoreceptor agonist
0,031  0,020  Phosphodiesterase 6B inhibitor
0,045  0,033  Adenylate cyclase 1 inhibitor
0,049  0,038  5 Hydroxytryptamine 1 agonist
0,072  0,063  Antineoplastic antibiotic
0,066  0,058  Calcium channel L-type blocker
0,038  0,031  Neurokinin 1 antagonist
0,107  0,100  Antismoking
0,079  0,072  mTOR complex 2 inhibitor
0,023  0,017  Phosphodiesterase 6G inhibitor
0,023  0,017  Phosphodiesterase 6H inhibitor
0,050  0,043  NMDA 2B receptor antagonist
0,055  0,049  Acetylcholine M5 receptor antagonist
0,037  0,031  Substance P antagonist
0,086  0,081  Antiemetic
0,171  0,168  Anxiolytic
0,135  0,134  UGT2B10 substrate
0,044  0,044  Topoisomerase II beta inhibitor
0,051  0,050  5 Hydroxytryptamine 7 agonist
0,110  0,109  UGT2B15 substrate

